![](https://events.knowledge-share.eu/wp-content/uploads/2020/10/Leonardo-Ricotti-150x150.jpeg)
Leonardo Ricotti
14:00 - 16:00
Artificial, bioartificial and tissue-engineered organs.
The device is a pacemaker for cardiac electrical stimulation without battery, implantable and miniaturized. The device is completely passive and can perform all the functions of the pacemakers and the electrocatheters, that is in case of alterations of normal cardiac physiology.
The invention has the great advantage of eliminating or reducing the complications of traditional devices, with a significant impact on the quality of life of patients who suffered from arrhythmic diseases or heart failure.
Stato del brevetto
DEPOSITATO
Numero di priorità
102019000006717
Data di priorità
10/05/2019
Licenza
ITALY
Problema
The cardiac stimulation pacemaker currently on the market have problems and complications, both short and long term, which can cause morbidity and mortality.
The features of current devices that create limitations and problems are related to their rechargeable battery that must be replaced periodically. Furthermore, they are bulky, sensitive to electromagnetic fields, expensive and they mean a high risk of infections.
Tecnologia e nostra soluzione
The solution proposed in the present invention is a passive device (without battery) for ventricular electrical stimulation produced with biocompatible and deformable materials. The medical device is capable of detecting the residual atrial contraction and converting it into an effective electric impulse. These modulated and synchronized electrical pulses are obtained exclusively from residual cardiac contractions, without needing for batteries and endocardiac cables.
Vantaggi
The medical device proposed is completely passive (without battery) and free of electrocatheters, as well as structurally simpler and cheaper than similar devices.
The miniaturized device provides a very small footprint, in addition to ease in the surgical placement and the better compliance of patient.
Thanks to its technical characteristics, the device is able to avoid any disturbances and abnormalities in the electrical conduction between the atrium and the ventricle, also involving a reduction in the maintenance surgeries and a lower risk of infections and complications.
TRL
Il team